Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W. Senefeld, Janis E. Blair, Peter Marks et al.|PLoS Medicine|2021Cited by 65
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L. Kunze, Michael J. Joyner, Peter Marks et al.|Nature Communications|2021Cited by 59
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L. Kunze, Janis E. Blair, Allan M. Klompas et al.|medRxiv|2021Cited by 7
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W. Senefeld, Michael J. Joyner, Joel T. Greenshields et al.|medRxiv|2021Cited by 7